Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
Make way for MiniMed! Medtronic's diabetes division has filed the necessary paperwork to go public. The company hopes to be traded on Nasdaq under the symbol MMED.
The Pennsylvania-based drug distributor announced it would be buying OneOncology, a physician-led specialty service group in which it already owned a minority stake. The company said the acquisition will complement its "pharmaceutical-centric strategy."
Paxton says the “woke” EHR giant is intentionally making it harder for patients and families to access historical medical data, violating state law. Epic denies the allegation.
Mark Cuban's startup Cost Plus Drugs and insurer Humana are said to be working on a deal that would allow Medicare Advantage patients to buy drugs directly from manufacturers. The terms of the agreement—which Forbes reports is in its early stages—are still unknown.
In what could be the first step in gaining a favorable recommendation for low-dose CT colonography from the U.S. Preventive Services Task Force (USPSTF), the organization has included the test in its draft research plan on colorectal screening
Two of New Jersey’s oldest imaging center operators, South Jersey Radiology Associates and Booth Radiology have merged forming a 13-location, 60 radiologist practice
The Centers for Medicare and Medicaid Services (CMS) and U.S. Department of Health and Human Services (HHS) Office of Inspector General (OIG) have published final rules to renew and revise the 2006 EHR exception and safe harbor from self-referral/anti-kickback requirements
A new report from Premier, Inc, indicates that hospital leadership is moving more slowly than previously signaled when it comes to active ACO participation.
Holders of Health Management Associates, Inc., (HMA) stock have overwhelmingly approved a $7.5 billion deal for HMA to be acquired by rival Community Health Systems, Inc., (CHS) creating the nation’s largest publicly-traded hospital company
Dean Norman Janes, the now former CEO of Imaging3, leaves the Burbank, Calif.-based developer of the Dominion Volumetric Imaging Scanner amid allegations that the intentionally mislead investors in the company about the true reasons the Dominion scanner failed three times to get U.S. Food & Drug Administration (FDA) 501k clearance
With less than 10 percent of EHR vendors whose products met 2011 edition meaningful use certification criteria going on to meet the 2014 edition criteria, hospitals and physician organizations who bought the wrong product may need to turn to the courts in hopes of getting some of their investment back